Discussion on the CDC ACIP meetings April 15 & 16, 2025

Dr. David Wiseman is a PhD Bioscientist with a background in pharmacy, pharmacology, immunology and experimental pathology. Since 1996 he has run his own medical product R&D consulting business, and since 2020 he has focused on Covid-19. He has made over 28 submissions on Covid-19 vaccines to government bodies including FDA, CDC and NIH. He is a contributor to Trial Site News. Follow him on X @AdhesionsOrg

Daniel O’Connor is the founder of TrialSiteNews, and you can read his opinion pieces at trialsitenews.com